Why you’re receiving CancerBot referrals
CancerBot partners with hospitals, patient-advocacy groups, and digital oncology platforms that help patients navigate treatment options. When our platform identifies that a patient fits your study’s inclusion/exclusion logic, we alert them and—with their consent—refer them to your research team.
You receive patients who are:
Biomarker-matched
Diagnosis-verified
Stage, line-of-therapy, and prior-treatment matched
Ready for screening and motivated to participate
No more high-volume, low-yield referrals. We send only qualified candidates.
For privacy and compliance reasons, access to detailed patient-level data is available only after a contract with CancerBot is in place.
How CancerBot increases your trial’s enrollment velocity
CancerBot currently prioritizes:
What researchers say
“CancerBot’s referrals have significantly improved the quality of our screening pool. Our team now spends time with the right patients, not sifting through ineligible charts.”
“The structured eligibility model is a game changer—its accuracy and clarity help us understand precisely why a patient was referred.”
